The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist)
According to modern concepts, human immune-mediated inflammatory diseases (IMIDs), depending on the prevailing mechanisms of immunopathogenesis, are divided into two main categories – autoimmune and autoinflammatory.At the same time, both autoimmune and autoinflammatory mechanisms are involved in th...
Saved in:
Main Authors: | E. L. Nasonov, M. Yu. Samsonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2022-07-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3172 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
by: E. L. Nasonov, et al.
Published: (2023-03-01) -
The use of Anakinra in a patient with a combination of two autoinflammatory diseases: Familial Mediterranean fever and gout
by: M. S. Eliseev, et al.
Published: (2023-04-01) -
ROLE OF INTERLEUKIN 1 IN THE DEVELOPMENT OF HUMAN DISEASES
by: E. L. Nasonov, et al.
Published: (2016-03-01) -
Assessing Efficacy of Interleukin-1 Blockade in Patients with Alcoholic Hepatitis: A Comprehensive Systematic Review of Emerging Evidence
by: Shree Rath, et al.
Published: (2025-07-01) -
Interleukin-1 is a Biological Marker in Heart Failure
by: A. M. Alieva, et al.
Published: (2022-12-01)